ARKG vs SCHV
ARK Genomic Revolution ETF vs Schwab US Large-Cap Value ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHV—
Schwab US Large-Cap Value ETF
Large-cap US value at low cost.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHV top holdings
Holdings data unavailable for SCHV.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost.